Manel Cascallo

Manel Cascallo, PhD

General Director,
EU Subsidiary

Manel Cascalló, PhD, has more than 12 years of experience as the CEO of various biotechnology companies. Dr. Cascalló is an expert in the clinical development of oncolytic viruses and the inventor of several patents for the use of adenoviruses as antitumoral agents.

Dr. Cascalló is the author of many peer-reviewed scientific publications and serves as an independent expert for the European Medicines Agency (EMA).